Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Cooper

Showing results (321-330 of 363) with videos related to

Pageof 37
Sort By:
AIDS (London, England)|April 1, 1997
Fertility and reproductive choice in women with HIV-1 infectionS V Thackway, V Furner, A Mijch, et al.
HIV Medicine|May 26, 2010
The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudyD A Cooper, D V Cordery, P Reiss, et al.
AIDS Research and Human Retroviruses|February 24, 1999
Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individualsE M Benson, J Clarkson, M Law, et al.
International Journal of STD & AIDS|March 24, 2011
Genital shedding of HIV after scheduled treatment interruptionJ Ananworanich, S J Kerr, P Vernazza, et al.
The Medical Journal of Australia|July 2, 1990
Voluntary HIV antibody testing among STD clinic patients: a pilot studyA M McDonald, B M Whyte, D Jacobs, et al.
Clinical Pharmacology and Therapeutics|January 2, 2009
A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adultsA Avihingsanon, J van der Lugt, S J Kerr, et al.
The Journal of Infectious Diseases|April 1, 1993
Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal diseaseS C Yeung, F Kazazi, C G Randle, et al.
AIDS (London, England)|October 1, 1993
Differences in time from HIV seroconversion to CD4+ lymphocyte end-points and AIDS in cohorts of homosexual menP J Veugelers, M T Schechter, B Tindall, et al.
AIDS (London, England)|May 1, 1994
Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. European-Australian Acyclovir Study GroupM S Youle, B G Gazzard, M A Johnson, et al.
Clinical and Experimental Immunology|April 1, 1993
Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patientsM J Boyle, M F Berger, M Tschuchnigg, et al.
Pageof 37

Showing results (321-330 of 363) with videos related to

Sort By:
Pageof 37
AIDS (London, England)|April 1, 1997
Fertility and reproductive choice in women with HIV-1 infectionS V Thackway, V Furner, A Mijch, et al.
HIV Medicine|May 26, 2010
The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudyD A Cooper, D V Cordery, P Reiss, et al.
AIDS Research and Human Retroviruses|February 24, 1999
Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individualsE M Benson, J Clarkson, M Law, et al.
International Journal of STD & AIDS|March 24, 2011
Genital shedding of HIV after scheduled treatment interruptionJ Ananworanich, S J Kerr, P Vernazza, et al.
The Medical Journal of Australia|July 2, 1990
Voluntary HIV antibody testing among STD clinic patients: a pilot studyA M McDonald, B M Whyte, D Jacobs, et al.
Clinical Pharmacology and Therapeutics|January 2, 2009
A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adultsA Avihingsanon, J van der Lugt, S J Kerr, et al.
The Journal of Infectious Diseases|April 1, 1993
Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal diseaseS C Yeung, F Kazazi, C G Randle, et al.
AIDS (London, England)|October 1, 1993
Differences in time from HIV seroconversion to CD4+ lymphocyte end-points and AIDS in cohorts of homosexual menP J Veugelers, M T Schechter, B Tindall, et al.
AIDS (London, England)|May 1, 1994
Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. European-Australian Acyclovir Study GroupM S Youle, B G Gazzard, M A Johnson, et al.
Clinical and Experimental Immunology|April 1, 1993
Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patientsM J Boyle, M F Berger, M Tschuchnigg, et al.
Pageof 37